{
    "applicationNumber": "BR 11 2021 015050-1",
    "filingDate": "31/01/2020",
    "grantDate": null,
    "title": "M\u00c9TODOS DE TRATAMENTO DE VETOR AAV PARA LIPOFUSCINOSE CER\u00d3IDE NEURONAL INFANTIL TARDIA TIPO 2",
    "nationalPhaseDate": [
        "30/07/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2020/016235",
        "pctDate": "31/01/2020",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/800.131",
            "priorityDate": "01/02/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2640"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2648"
        }
    ],
    "inventors": [
        "DAVID WILLIAM ANDERSON",
        "MARYANN TOTO",
        "SUE EI DASEN"
    ],
    "holders": [
        214369
    ],
    "ipcCodes": [
        "A61K 48/00",
        "A61P 37/06",
        "A61K 38/46",
        "A61K 31/436",
        "A61K 38/13",
        "C07K 14/015"
    ]
}